Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Piazza

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|March 12, 2019
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort studyGregorio Barilà, Nicolò Compagno, Albana Liço, et al.
Cancer Cell International|January 26, 2025
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancerElena Lastraioli, Jessica Iorio, Francesco Piazza, et al.
Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
British Journal of Haematology|July 6, 2018
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndromeAndrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
American Journal of Hematology|October 31, 2025
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the LiteratureGiovanni Leone, Mattia D'Antiga, Michela Pelloso, et al.
Blood Cancer Journal|June 13, 2018
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferationGregorio Barilà, Antonella Teramo, Giulia Calabretto, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Frontiers in Oncology|September 20, 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVDAlessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, et al.
Cancers|March 28, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease CourseFrancesco Angotzi, Alessandro Cellini, Valeria Ruocco, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|March 12, 2019
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort studyGregorio Barilà, Nicolò Compagno, Albana Liço, et al.
Cancer Cell International|January 26, 2025
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancerElena Lastraioli, Jessica Iorio, Francesco Piazza, et al.
Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
British Journal of Haematology|July 6, 2018
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndromeAndrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
American Journal of Hematology|October 31, 2025
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the LiteratureGiovanni Leone, Mattia D'Antiga, Michela Pelloso, et al.
Blood Cancer Journal|June 13, 2018
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferationGregorio Barilà, Antonella Teramo, Giulia Calabretto, et al.
British Journal of Haematology|August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activityLivio Trentin, Marta Miorin, Monica Facco, et al.
Frontiers in Oncology|September 20, 2024
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVDAlessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, et al.
Cancers|March 28, 2024
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease CourseFrancesco Angotzi, Alessandro Cellini, Valeria Ruocco, et al.
Pageof 21